[1] |
Stuart CH, Schwartz SA, Beeson TJ, et al. Enterococcus faecalis: Its role in root canal treatment failure and current concepts in retreatment[J]. J Endod, 2006, 32(2): 93-98.
|
[2] |
Siqueira JF Jr, Rôças IN. Polymerase chain reaction-based analysis of microorganisms associated with failed endodontic treatment[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2004, 97(1): 85-94.
|
[3] |
Alghamdi F, Shakir M. The influence of Enterococcus faecalis as a dental root canal pathogen on endodontic treatment: A systematic review[J]. Cureus, 2020, 12(3): e7257.
|
[4] |
Lee SH, Baek DH. Antibacterial and neutralizing effect of human β-defensins on Enterococcus faecalis and Enterococcus faecalis lipoteichoic acid[J]. J Endod, 2012, 38(3): 351-356.
|
[5] |
Ghosh C, Luong G, Sun Y. A snapshot of the PD-1/PD-L1 pathway[J]. J Cancer, 2021, 12(9): 2735-2746.
doi: 10.7150/jca.57334
pmid: 33854633
|
[6] |
孙宏晨, 李杏. 纳米载药系统靶向肿瘤相关巨噬细胞用于肿瘤治疗的研究进展[J]. 口腔医学研究, 2019, 35(6): 511-516.
doi: 10.13701/j.cnki.kqyxyj.2019.06.001
|
[7] |
Yu JX, Hodge JP, Oliva C, et al. Trends in clinical development for PD-1/PD-L1 inhibitors[J]. Nat Rev Drug Discov, 2020, 19: 163-164.
doi: 10.1038/d41573-019-00182-w
pmid: 32127660
|
[8] |
Sperk M, van Domselaar R, Neogi U. Immune checkpoints as the immune system regulators and potential biomarkers in HIV-1 infection[J]. Int J Mol Sci, 2018, 19(7): 2000.
|
[9] |
Zhang JH, Wang CM, Zhang P, et al. Expression of programmed death 1 ligand 1 on periodontal tissue cells as a possible protective feedback mechanism against periodontal tissue destruction[J]. Mol Med Rep, 2016, 13(3): 2423-2430.
doi: 10.3892/mmr.2016.4824
pmid: 26847035
|
[10] |
Betzler AC, Theodoraki MN, Schuler PJ, et al. NF-κB and its role in checkpoint control[J]. Int J Mol Sci, 2020, 21(11): E3949.
|
[11] |
孙佳瑶, 宗斌, 谢雨桐, 等. Wnt/β-catenin通路与NF-kB通路的交叉调控对间充质干细胞分化的影响[J]. 口腔医学, 2023, 9(2): 170-175.
|
[12] |
Li H, Xia JQ, Zhu FS, et al. LPS promotes the expression of PD-L1 in gastric cancer cells through NF-κB activation[J]. J Cell Biochem, 2018, 119(12): 9997-10004.
doi: 10.1002/jcb.27329
pmid: 30145830
|
[13] |
Wang LN, Jin HW, Ye DD, et al. Enterococcus faecalis lipoteichoic acid-induced NLRP3 inflammasome via the activation of the nuclear factor kappa B pathway[J]. J Endod, 2016, 42(7): 1093-1100.
|
[14] |
Marçal JRB, Samuel RO, Fernandes D, et al. T-helper cell type 17/regulatory T-cell immunoregulatory balance in human radicular cysts and periapical granulomas[J]. J Endod, 2010, 36(6): 995-999.
doi: 10.1016/j.joen.2010.03.020
pmid: 20478453
|
[15] |
Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease[J]. Nature, 2013, 496(7446): 445-455.
|
[16] |
Hackstein H, Hagel N, Knoche A, et al. Skin TLR7 triggering promotes accumulation of respiratory dendritic cells and natural killer cells[J]. PLoS One, 2012, 7(8): e43320.
|
[17] |
He X, Xu CQ. Immune checkpoint signaling and cancer immunotherapy[J]. Cell Res, 2020, 30(8): 660-669.
doi: 10.1038/s41422-020-0343-4
pmid: 32467592
|
[18] |
Li KQ, Chen YH, Lin YH, et al. PD-1/PD-L1 blockade is a potent adjuvant in treatment of Staphylococcus aureus osteomyelitis in mice[J]. Mol Ther, 2023, 31(1): 174-192.
|
[19] |
Jiang XJ, Wang J, Deng XY, et al. Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape[J]. Mol Cancer, 2019, 18(1): 10.
doi: 10.1186/s12943-018-0928-4
pmid: 30646912
|
[20] |
Yearley JH, Gibson C, Yu N, et al. PD-L2 expression in human tumors: Relevance to anti-PD-1 therapy in cancer[J]. Clin Cancer Res, 2017, 23(12): 3158-3167.
doi: 10.1158/1078-0432.CCR-16-1761
pmid: 28619999
|
[21] |
Shelby A, Pendleton C, Thayer E, et al. PD-L1 correlates with chemokines and cytokines in gingival crevicular fluid from healthy and diseased sites in subjects with periodontitis[J]. BMC Res Notes, 2020, 13(1): 532.
doi: 10.1186/s13104-020-05376-9
pmid: 33187554
|
[22] |
Delgado RJR. Programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in chronic apical periodontitis[J]. Eur Endod J, 2019, 4(1): 3-8.
|
[23] |
Esberg A, Isehed C, Holmlund A, et al. Serum proteins associated with periodontitis relapse post-surgery: A pilot study[J]. J Periodontol, 2021, 92(12): 1805-1814.
doi: 10.1002/JPER.21-0089
pmid: 33813739
|
[24] |
Cavalla F, Letra A, Silva RM, et al. Determinants of periodontal/periapical lesion stability and progression[J]. J Dent Res, 2021, 100(1): 29-36.
|
[25] |
Liu XW, Yang L, Tan XL. PD-1/PD-L1 pathway: A double-edged sword in periodontitis[J]. Biomed Pharmacother, 2023, 159: 114215.
|
[26] |
Antonangeli F, Natalini A, Garassino MC, et al. Regulation of PD-L1 expression by NF-κB in cancer[J]. Front Immunol, 2020, 11: 584626.
|
[27] |
Arato I, Milardi D, Giovagnoli S, et al. In “vitro” lps-stimulated sertoli cells pre-loaded with microparticles: intracellular activation pathways[J]. Front Endocrinol, 2021, 11: 611932.
|
[28] |
Ma L, Qin N, Wan W, et al. TLR9 activation induces immunosuppression and tumorigenesis via PARP1/PD-L1 signaling pathway in oral squamous cell carcinoma[J]. Am J Physiol Cell Physiol, 2024, 326(2): C362-C381.
|
[29] |
Zhang Q, Mu X, Dong H, et al. Pulmonary endothelium-derived PD-L1 induced by the H9N2 avian influenza virus inhibits the immune response of T cells[J]. Virol J, 2020, 17(1): 92.
doi: 10.1186/s12985-020-01341-x
pmid: 32631356
|
[30] |
Ritprajak P, Azuma M. Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma[J]. Oral Oncol, 2015, 51(3): 221-228.
doi: 10.1016/j.oraloncology.2014.11.014
pmid: 25500094
|
[31] |
Yi M, Niu MK, Xu LP, et al. Regulation of PD-L1 expression in the tumor microenvironment[J]. J Hematol Oncol, 2021, 14(1): 1-13.
|